Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tegileridine versus sufentanil PCIA with TAP block for postoperative analgesia in elderly abdominal surgery patients
ChiCTR2600133849Phase 4Recruiting
- Sponsor
- Chaohu Hospital of Anhui Medical University
- Start
- Sep 2026
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in postoperative pain comparing Sufentanil Group with Tegileridine Group (2 arms). Primary endpoints: Difference in cumulative pain intensity over 24 hours and NRS score at rest 24 hours postoperatively. Started Sep 2026; status: recruiting.
02
Drugs
tegileridinesufentanil
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ChiCTR2600133849.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600133849.